Comparison of Two GIC's in the Restoration of Posterior Class II Lesions in the Primary Dentition - Trial NCT05965297
Access comprehensive clinical trial information for NCT05965297 through Pure Global AI's free database. This phase not specified trial is sponsored by DMG Dental Material Gesellschaft mbH and is currently Not yet recruiting. The study focuses on Dental Caries. Target enrollment is 140 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
DMG Dental Material Gesellschaft mbH
Timeline & Enrollment
N/A
Aug 01, 2023
Aug 01, 2030
Primary Outcome
Survival rate of Class II restorations
Summary
This study will investigate the clinical performance of a novel restorative glass ionomer
 (DeltaFil, DMG) in comparison to an established restorative glass ionomer (Riva Self Cure HV,
 SDI) in the restoration of Class II cavities in primary molars.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05965297
Device Trial